Navigation Links
Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172
Date:8/14/2008

e (aPTT). The highest infusion dose rate tested, 6.0 mg/kg/hr, resulted in an average ACT per subject ranging from 373 to 414 seconds and an increase of approximately three times baseline. Average PT values per subject ranged from 56 to 92 seconds and had an increase of approximately five times baseline. Average aPTT values per subject ranged from 130 to 178 seconds and had an increase of approximately five times baseline. All measurements were maintained stably throughout the four-hour infusion. Once the infusion ended, the ACT and other coagulation parameters showed a rapid return toward baseline, consistent with the short plasma half-life of NU172 observed in the Phase 1a trial. In addition, NU172 was well-tolerated with no serious adverse events.

"In this study, we were able to identify a dose that meets or exceeds the level of anticoagulation needed for the indications we plan to evaluate, including CABG surgery," said Dr. Ted W. Love, chairman and chief executive officer of Nuvelo. "In addition to supporting our previous proof-of-concept data, the Phase 1b study shows that anticoagulation with NU172 can be maintained for four hours, which is longer than a typical CABG procedure. We are on track to launch a Phase 2 study evaluating NU172 in the fourth quarter of 2008 or the first quarter of 2009."

Approximately 450,000 CABG procedures, 50 million dialysis procedures, and 1.2 million PCIs are performed annually in the U.S. During these procedures, anticoagulants are given to prevent blood clotting. In CABG procedures and often in dialysis, the anticoagulation effect of heparin must be reversed with protamine once the procedure has been completed.

About Aptamers and NU172

Aptamers are chemically synthesized single-stranded nucleic acids that form well-defined three-dimensional shapes, allowing them to bind target molecules in a manner that is conceptually similar to antibodies. Characteristics of aptamers include high specificity and a
'/>"/>

SOURCE Nuvelo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
2. Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172
3. Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models
4. Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
5. Nuvelo Initiates Phase 1 Clinical Trial of Thrombin Inhibitor, NU172
6. Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
7. Nuvelo Announces Alfimeprase SONOMA-2 Catheter Occlusion Data Presentation Webcast and Conference Call
8. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
9. NewCardio Announces Positive Results From Third Clinical Validation Study
10. Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus
11. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... OAKS, Calif. , May 23, 2013 Amgen ... Bank 38 th Annual  Healthcare Conference on Thursday, May ... Boston , beginning at 9:20 a.m. Eastern Daylight Time. ... Relations at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
(Date:5/23/2013)... -- A recently published clinical study conducted at TOPS Comprehensive ... demonstrates that 3D mammography (breast tomosynthesis) significantly reduces unnecessary ... The study, "Implementation of Breast Tomosynthesis in a Routine ... Stephen L. Rose , MD, and published ... of Roentgenology (AJR). The AJR is the scientific ...
(Date:5/23/2013)... Anthem Blue Cross patients with HIV/AIDS may ... to obtain their medications by mail order under a ... LLC.  The lawsuit, filed in January ... mandatory mail order program announced late last year illegally ... "This settlement brings to a close a nerve-racking ...
Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
... George Products Company, Inc. has announced the addition ... OASIS Inspection Systems. Florida Metrology, based ... OASIS Inspection Systems is a line of highly accurate ... control departments across the United States. Tim Row of ...
... Sutro Biopharma, a biopharmaceutical company developing both ... properties, today announced that it has appointed Trevor ... Hallam will lead Sutro,s ongoing efforts in the ... platform for the research and development of novel ...
Cached Medicine Technology:Florida Metrology To Distribute OASIS Inspection Systems 2Sutro Biopharma Appoints Trevor Hallam, Ph.D., as Chief Scientific Officer 2
(Date:5/24/2013)... California (PRWEB) May 24, 2013 Residents ... comes to boot camp classes. Fitness expert, and Certified ... series of Kettlebell X Bootcamps in San Diego, California. ... variety of different class times offered. Initial sign-ups ... , “I’ve been teaching Kettlebell for years. ...
(Date:5/24/2013)... DiscountHumidifiers.com, an eCommerce store specializing in economical humidification ... line of humidifiers. These tastefully designed humidifiers are ... styles to choose from. , The ... piece – yet its functionality is not easily recognized. ... an inconspicuous humidifying appliance. With the built-in aroma diffuser, ...
(Date:5/24/2013)... Impacts World 2013 from May 27-30th brings together ... and civil society to discuss a new vision ... and scales. , Webcast of opening press conference ... to 1:55pm and opening plenary from 2pm: ... Connie Hedegaard, EU Commissioner for Climate Action, Joseph ...
(Date:5/24/2013)... NY (PRWEB) May 24, 2013 The ... Cellular Dynamics International (CDI) exclusive license rights to ... and regenerative medicine applications. These cells are capable of ... heart, including cardiomyocytes, endothelial cells, and vascular smooth muscle ... therapeutic for damaged heart tissue. , The original agreement ...
(Date:5/24/2013)... Certain statins -- the widely used cholesterol-lowering drugs ... 2 diabetes, a new study suggests. The ... name Lipitor), rosuvastatin (Crestor) and simvastatin (Zocor), the ... Ontario residents, researchers in Canada found that the ... patients prescribed statins. Still, people taking Lipitor had ...
Breaking Medicine News(10 mins):Health News:DiscountHumidifiers.com Announces the Launch of the New Broksonic Humidifiers to their Online Store 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 3Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 4Health News:Could Statins Raise Diabetes Risk? 2Health News:Could Statins Raise Diabetes Risk? 3
... , Project Bread addresses ... , BOSTON, Nov. 20 Project Bread, the state,s leading ... on hunger in the Commonwealth. The disquieting trends described in ... in the Commonwealth struggling with hunger. Food insecurity has found ...
... , MOUNTAIN VIEW, Calif., Nov. 20 Omnicell, Inc. ... healthcare facilities, announced today the company will present at the 21st ... New York, NY. , Omnicell Speakers: Randall A. ... CFO , Date: Tuesday, December 1, 2009 , Time: ...
... , , BATON ROUGE, La., Nov. 20 ... (LAHP) today warned that Louisianians could experience higher health care ... should become law. , According to Gil Dupre, chief executive ... care reform since the beginning of the national debate. ...
... , WASHINGTON, Nov. 20 The Senate,s newly ... infringes on Americans, health-insurance choices and medical privacy, says ... (IHF) -- a patients, rights group in Washington, D.C. ... , Require nearly every legal resident to buy ...
... , MARINA DEL REY, Calif., Nov. 20 Heritage Provider Network, ... as of November 6, 2009, Lakeside Medical Systems, Inc., as well ... Organization, part of the HPN family. , "We first and foremost ... HPN family are dedicated to maintaining the high level of care ...
... 20 Fear about the risk of surgery is among ... valve replacement surgery, according to a study by physicians at ... year, former First Lady Barbara Bush and comedian Robin Williams ... missing out on the potentially life-saving surgery. , In the ...
Cached Medicine News:Health News:554,000 in Massachusetts Struggle to Put Food on the Table 2Health News:554,000 in Massachusetts Struggle to Put Food on the Table 3Health News:554,000 in Massachusetts Struggle to Put Food on the Table 4Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2Health News:Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians 2Health News:Senate Mandatory Health-Insurance Bill Infringes on Choice and Privacy 2Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 2Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 3Health News:Half of Eligible Patients Do Not Get Aortic Valve Replacement 2
... Stand Magnifier offers versatility across a ... lens and the light are adjustable. ... hand held objects can be worked ... parallel to the work surface, lay ...
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
... Central platform with integrated neck. Piston ... an internal spring to recoil to ready ... precision milled cavity in platform. Accepts disposable ... Designed for the use in in the ...
... TLS Surgical Markers allows ... incision sites with a scrub-resistant, ... Surgical Markers are provided sterile, ... individually packaged in peel pouches. ...
Medicine Products: